Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Lucid Diagnostics Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 49 | 72 | +23 |
| Shares | 9.39M | 19.0M | +9.57M (+101.9%) |
| Value | $14.0M | $21.7M | +$7.79M (+55.8%) |
New holders (32)
Institutions that held Lucid Diagnostics Inc. at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (9)
Institutions that held Lucid Diagnostics Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Ghisallo Capital Management LLC | 422,004 | $628.8K |
| Millennium Management LLC | 204,047 | $304.0K |
| Citadel Advisors LLC | 121,430 | $180.9K |
| Cubist Systematic Strategies, LLC | 26,048 | $38.8K |
| Northwestern Mutual Wealth Management Co | 24,559 | $36.6K |
| HRT Financial LP | 16,308 | $24.0K |
| Mariner, LLC | 10,163 | $15.1K |
| Cambridge Investment Research Advisors, Inc. | 10,000 | $15.0K |
| Binnacle Investments Inc | 25 | $37 |